Noticias de BCRX_US

Noticias del mercado

Últimas noticias sobre BCRX_US — 83 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: BCRX_US ✕ 83 resultados
10/04/2026 BCRX_US — ChartMill ES ← EN
Precio, cotización y gráfico de acciones de BCRX | BIOCRYST PHARMACEUTICALS INC (NASDAQ: BCRX)
09/04/2026 BCRX_US — Sahm
A Look At BioCryst Pharmaceuticals (BCRX) Valuation After New R&D Leadership Appointment
07/04/2026 BCRX_US — Stock Titan
Sandeep Menon of BIOCRYST PHARMACEUTICALS (BCRX) submits Form 3
07/04/2026 BCRX_US — Stock Titan
BioCryst (BCRX) Chief R&D Officer receives large stock option and RSU inducement grants
07/04/2026 BCRX_US — MarketScreener
RBC Capital Adjusts BioCryst Pharmaceuticals PT to $14 From $13, Maintains Outperform Rating
06/04/2026 BCRX_US — Quiver Quantitative ES ← EN
BioCryst Pharmaceuticals nombra al Dr. Sandeep M. Menon director de investigación y desarrollo
06/04/2026 BCRX_US — MarketBeat
BioCryst Pharmaceuticals (NASDAQ:BCRX) Trading Up 6% - Here's What Happened
06/04/2026 BCRX_US — GlobeNewswire
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
06/04/2026 BCRX_US — Stock Titan
BioCryst taps AMVUTTRA, PAXLOVID veteran to lead R&D effort
03/04/2026 BCRX_US — GlobeNewswire
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/04/2026 BCRX_US — Stock Titan
12 new BioCryst hires receive stock awards tied to 157,300 shares
01/04/2026 BCRX_US — vinhcong.tayninh.gov.vn ES ← EN
Análisis de acciones de BCRX: actualización de BioCryst Pharmaceuticals Inc. sobre una caída del 1,47% a $ 9,38
30/03/2026 BCRX_US — MarketBeat
BioCryst Pharmaceuticals, Inc. $BCRX Shares Sold by JPMorgan Chase & Co.
27/03/2026 BCRX_US — Investing.com
Earnings call transcript: BioCryst Q4 2025 shows strong growth, stock dips
26/03/2026 BCRX_US — Stock Titan
Vanguard amends Schedule 13G — BioCryst (BCRX) ownership shown as 0
25/03/2026 BCRX_US — MSN
BioCryst appoints Charlie Gayer to succeed Jon Stonehouse as CEO
24/03/2026 BCRX_US — GuruFocus
Insider Sell: Theresa Heggie Sells 49,933 Shares of BioCryst Pha
24/03/2026 BCRX_US — Stock Titan
Option exercise and sale by BioCryst (BCRX) director Theresa Heggie
23/03/2026 BCRX_US — MSN ES ← EN
Las acciones de BioCryst suben después de horas debido al rumor de los grandes pretendientes farmacéuticos: el sentimiento minorista alcanza el pico de 2026
23/03/2026 BCRX_US — Stocktwits
Why Did BCRX Stock Surge Over 10% In After-Hours Trading Today?

Página 2 de 5

keyboard_arrow_up